ROZUCOR 10

About

Rosuvastatin is a highly potent HMG-CoA reductase inhibitor, belonging to the statin class of medications, widely prescribed for the management of dyslipidemia and the comprehensive reduction of cardiovascular disease risk. Its primary mechanism involves competitively inhibiting HMG-CoA reductase, a crucial enzyme in the liver responsible for the rate-limiting step of cholesterol biosynthesis. This inhibition leads to a significant reduction in the production of endogenous cholesterol, particularly lowering levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides. Additionally, rosuvastatin effectively increases high-density lipoprotein cholesterol (HDL-C). Its superior efficacy in achieving substantial LDL-C reduction makes it a cornerstone in both the primary and secondary prevention strategies for atherosclerotic cardiovascular disease, including myocardial infarction and stroke, thereby improving long-term patient outcomes and reducing morbidity and mortality.

Uses

• Primary hypercholesterolemia and mixed dyslipidemia.
• Homozygous familial hypercholesterolemia.
• Prevention of major cardiovascular events in high-risk individuals.
• Primary prevention of coronary heart disease.

Directions For Use

Take one tablet orally once daily, at any time of day, with or without food, as prescribed.
Swallow the tablet whole with water.

Benefits

• Highly effective in lowering LDL-C and total cholesterol.
• Significantly reduces triglyceride levels.
• Increases HDL-C more effectively than some other statins.
• Reduces the risk of heart attack, stroke, and other cardiovascular events.
• Slows the progression of atherosclerosis.
• Well-established efficacy and safety profile.

Side Effects

• Muscle pain (myalgia)
• Headache
• Nausea
• Abdominal pain
• Constipation
• Asthenia (weakness)
• Dizziness
• Elevated liver enzymes
• Diabetes mellitus (increased risk)
• Proteinuria (dose-dependent)
• Rhabdomyolysis (rare but serious muscle breakdown)
• Hypersensitivity reactions

Safety Measures

• Alcohol - Excessive alcohol consumption can increase the risk of liver problems associated with statins. It is advisable to limit alcohol intake while on rosuvastatin.
• Pregnancy - Rosuvastatin is contraindicated in pregnancy due to the potential for fetal harm. It should be discontinued immediately if pregnancy is detected.
• Breastfeeding - Rosuvastatin is contraindicated during breastfeeding as it may be excreted in breast milk and could potentially harm the infant.
• Liver - Rosuvastatin is contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. Liver function tests should be monitored.
• Kidney - Use with caution in patients with severe renal impairment (creatinine clearance <30 mL/min), as dose adjustment may be necessary.
• Lung - Rosuvastatin does not have direct significant effects on lung function. No specific precautions are typically needed for patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.